Hi @Mason14
That's an excellent brief introduction to this topic.
Thanks for posting it.
It waa already known that the other FTO inhibitors aren't cardioprotective.
But it's news to me that they're cardiotoxic.
Thanks for pointing that out.
I wonder why RAC has never mentioned it.
I guess I shouldn't be too surprised. Bisantrene is also cardiotoxic, but it self-rescues.
If the other FTO inhibitors don't self-rescue, only their cardiotoxicity remains.
Yes, this further increases the uniqueness of bisantrene.
Well done Mason (and Pecks).
PS. If by chance you discover bisantrene's self-rescue mechanism of action, please don't publish it anywhere before RAC has lodged its patent.
Cardioprotection thread, page-455
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $272.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 315 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 50 | 1 |
View Market Depth
| Last trade - 10.02am 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.57 |
Change
0.000 ( 1.57 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.58 | $1.56 | 1267 | ||
| Last updated 10.10am 05/06/2024 ? | |||||
| RAC (ASX) Chart |
Day chart unavailable